EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota

Jun-Jie Hou, A-Huo Ma, Yue-Hua Qin

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1279172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Jun-Jie Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shaoxing People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Microbiota. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disease that affects more than 3.5 million people, with rising prevalence. It deeply affects patients’ daily life, increasing the burden on patients, families, and society. Presently, the etiology of IBD remains incompletely clarified, while emerging evidence has demonstrated that altered gut microbiota and decreased aryl hydrocarbon receptor (AHR) activity are closely associated with IBD. Furthermore, microbial metabolites are capable of AHR activation as AHR ligands, while the AHR, in turn, affects the microbiota through various pathways. In light of the complex connection among gut microbiota, the AHR, and IBD, it is urgent to review the latest research progress in this field. In this review, we describe the role of gut microbiota and AHR activation in IBD and discussed the crosstalk between gut microbiota and the AHR in the context of IBD. Taken as a whole, we propose new therapeutic strategies targeting the AHR–microbiota axis for IBD, even for other related diseases caused by AHR-microbiota dysbiosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesMicrobiotaHumansReceptors, Aryl HydrocarbonDysbiosis

Stichwörter der Autor:innen

aryl hydrocarbon receptorgut microbiotainflammatory bowel diseaseinterplaytherapy

Substanzen

Receptors, Aryl Hydrocarbon

Autor:innen und Institutionen

  • Department of Gastroenterology, Shaoxing People's Hospital, Shaoxing, China.

Zitieren

APA

Hou, J. J., Ma, A. H., & Qin, Y. H. (2023). Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1279172

Vancouver

Hou JJ, Ma AH, Qin YH. Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1279172

BibTeX
@article{Hou2023,
  author = {Hou, Jun-Jie and Ma, A-Huo and Qin, Yue-Hua},
  title = {Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1279172}
}
Kostenlos starten →